FDA issues new Byetta alert on more serious pancreatitis cases
This article was originally published in Scrip
Executive Summary
The US FDAhas alerted US doctors to the fact that Lillyand Amylin's injectable type 2 diabetes drug Byetta (exenatide) has been associated with six cases of haemorrhagic or necrotising pancreatitis – and that of the six cases, two patients died and four are recovering.